FIRM FIXED PRICENO SET ASIDE USED.

MARLEX PHARMACEUTICALS INC - NEW AWARD FOR ALENDRONATE TABLETS WITH MARLEX PHARMACEUTICALS, INC. PERIOD OF PERFORMANCE IS 5/21/2026 - 5/20/2027.

PIID: 36E79726D0016Solicitation ID: 36E79725R0069

Signed Date: Jan 7, 2026Effective Date: May 21, 2026

Vendor

MARLEX PHARMACEUTICALS INC

NAICS

325412

Signed Date

Jan 7, 2026

Key Details

Dollars Obligated

Base & All Options

$4.4M

Awarding Agency

Department of Veterans Affairs

Awarding Sub-Agency

Department of Veterans Affairs

NAICS Code

325412 - PHARMACEUTICAL PREPARATION MANUFACTURING

Product Service Code

6505 - DRUGS AND BIOLOGICALS

Extent Competed

FULL AND OPEN COMPETITION

Number of Offers

Description

NEW AWARD FOR ALENDRONATE TABLETS WITH MARLEX PHARMACEUTICALS, INC. PERIOD OF PERFORMANCE IS 5/21/2026 - 5/20/2027.

Context & Analysis

On Jan 7, 2026, Department of Veterans Affairs to MARLEX PHARMACEUTICALS INC for new award for alendronate tablets with marlex pharmaceuticals, inc. period of performance is 5/21/2026 - 5/20/2027.. The award is classified under NAICS 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING and issued as a firm fixed price contract. Competition extent: full and open competition with 2 offers received. The procurement used a NO SET ASIDE USED. set-aside.